1994
DOI: 10.1016/0014-2999(94)90542-8
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation by carbachol of mucus gel thickness in rat stomach involves nitric oxide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
24
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(27 citation statements)
references
References 7 publications
2
24
0
Order By: Relevance
“…This study did not resolve whether CCh's luminal actions were direct (via receptors on mucosal cells or cholinergic axons) or indirect (via receptors on mucosal noncholinergic axons). However, in vivo actions of luminal cholinergic agents have been reported: luminal CCh stimulated gastric mucus release (69); oral administration of CCh induced cholinergic symptoms (72); and luminal pilocarpin altered intestinal transmucosal potential difference (16). The lack of observed responses to luminally applied CCh in vitro (32) may be explained by dysfunction of the severed mucosal axon plexuses under in vitro experimental conditions.…”
Section: Carbachol-induced Membrane Traffickingmentioning
confidence: 98%
See 1 more Smart Citation
“…This study did not resolve whether CCh's luminal actions were direct (via receptors on mucosal cells or cholinergic axons) or indirect (via receptors on mucosal noncholinergic axons). However, in vivo actions of luminal cholinergic agents have been reported: luminal CCh stimulated gastric mucus release (69); oral administration of CCh induced cholinergic symptoms (72); and luminal pilocarpin altered intestinal transmucosal potential difference (16). The lack of observed responses to luminally applied CCh in vitro (32) may be explained by dysfunction of the severed mucosal axon plexuses under in vitro experimental conditions.…”
Section: Carbachol-induced Membrane Traffickingmentioning
confidence: 98%
“…Stimulation of the cholinergic gastrointestinal parasympathetic nervous system produces fluid, electrolyte, and mucus secretion (43,69). We used the cholinergic agonist CCh to examine its effect on the subcellular distribution of the four ion transporters (Figs.…”
Section: Carbachol-induced Redistribution Of Nhe3 Cftr Nbce1 and Nmentioning
confidence: 99%
“…The first two groups mentioned above studied isolated cell preparations making it very difficult to draw parallels between such systems and whole tissue with its surrounding influences as in our system. However, Brown et al (1992) and Price et al (1994) studied NO-induced increases in mucus gel thickness in rat gut in vivo and concluded that NO was involved in the pathway by which a muscarinic acetylcholine receptor agonist (carbacol) stimulates mucus secretion. We found L-NMMA and the NO donor FK409 to be without effect on ACh-induced mucus secretion indicating that NO plays no role in muscarinic agonist-induced secretion in ferret trachea.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, NO is the dominant non-adrenergic, non-cholinergic (NANC) neurotransmitter of airway bronchodilator nerves (Lei et al, 1993;Belvisi et al, 1995), as well as being a regulator of pulmonary blood flow (Barnes & Liu, 1995), bronchial plasma exudation (Erjefalt et al, 1994), and airway ciliary beat frequency (Jain et al, 1993). In rat stomach NO donors increase mucus gel thickness (Brown et al, 1992), an effector role that may be linked to cholinergic activation of gastric mucus secretion (Price et al, 1994). However, the role of NO in control of secretion of airway mucus, and in particular on neurogenic mucus secretion, remains unexplored.…”
Section: Introductionmentioning
confidence: 99%
“…Mucus secretion is increased by luminal acid (19,33) and the neuro-and inflammatory mediators acetylcholine and interleukin-1 (8), vasoactive intestinal polypeptide (15), secretin (16,19), and guanylin (10) in duodenum. In the stomach and intestine, mucus secretion and gel thickness are increased by prostaglandins (5,20,24,36), pentagastrin (26,45), carbachol (30,31), nitric oxide (7,30), bradykinin (41) and phorbol esters (29). Of these factors, prostaglandins, products of the cyclooxygenase (COX) pathway, are of paramount clinical importance, because COX inhibition is an important cause of clinical duodenal ulceration (38).…”
mentioning
confidence: 99%